Form 4 for ANRO Alto Neuroscience, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | ANRO | Etkin Amit | Pres AND CEO, Dir | A - Grant | $0.00 | +34.7K | 1.24M | +3% | $0 |
| D | 2024-03-05 | 2024-03-01 | ANRO | Etkin Amit | Pres AND CEO, Dir | A - Grant | $0.00 | +223.0K | 223.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 34,711 | $0.00 | 1,240,176 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs shall vest in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Person's continuous service through each such vesting date. (F2) Each RSU represents a contingent right to receive one share of common stock. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-01 | A | A | 223,000 | $0.00 | 223,000 | D | $14.88 · — to 2034-02-28 | 223,000 Common Stock | (F3) 25% of the shares underlying the option shall vest on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |